69 related articles for article (PubMed ID: 34487080)
1. MRI fat fraction imaging of nodal and bone metastases in prostate cancer.
Qin C; Goldberg O; Kakar G; Wan S; Haroon A; Azam A; Adeleke S
Eur Radiol; 2023 Aug; 33(8):5851-5855. PubMed ID: 36928564
[TBL] [Abstract][Full Text] [Related]
2. Local Staging of Prostate Cancer at MRI: What the Urologist and Radiation Oncologist Want to Know.
Gottumukkala RV; Lee LK; Tu W; Tempany CM; Fennessy FM
Radiographics; 2023 Sep; 43(9):e220100. PubMed ID: 37561642
[TBL] [Abstract][Full Text] [Related]
3. Establishment and validation of a predictive model for bone metastasis in prostate cancer patients based on multiple immune inflammatory parameters.
Wang Z; Sun Y; Ren W; Guan Z; Cheng J; Pei X; Dong Q
Am J Transl Res; 2023; 15(2):1502-1509. PubMed ID: 36915765
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric MRI - local staging of prostate cancer and beyond.
Caglic I; Kovac V; Barrett T
Radiol Oncol; 2019 May; 53(2):159-170. PubMed ID: 31103999
[TBL] [Abstract][Full Text] [Related]
5. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
Fischerová D; Cibula D
Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
[TBL] [Abstract][Full Text] [Related]
6. The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases. A case report.
Belmonte M; Saia G; Zugni F; Alessi S; Colombo A; Summers PE; Luzzago S; Marvaso G; Musi G; De Cobelli O; Jereczek-Fossa BA; Petralia G
Acta Biomed; 2021 Sep; 92(4):e2021214. PubMed ID: 34487080
[TBL] [Abstract][Full Text] [Related]
7. Comparison of
Zhang Q; Zang S; Zhang C; Fu Y; Lv X; Zhang Q; Deng Y; Zhang C; Luo R; Zhao X; Wang W; Wang F; Guo H
J Transl Med; 2017 Nov; 15(1):230. PubMed ID: 29115970
[TBL] [Abstract][Full Text] [Related]
8. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified "all-in-one" imaging approach?
Pasoglou V; Larbi A; Collette L; Annet L; Jamar F; Machiels JP; Michoux N; Vande Berg BC; Tombal B; Lecouvet FE
Prostate; 2014 May; 74(5):469-77. PubMed ID: 24375774
[TBL] [Abstract][Full Text] [Related]
11. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
[TBL] [Abstract][Full Text] [Related]
12. Bone metastases.
Coleman RE; Croucher PI; Padhani AR; Clézardin P; Chow E; Fallon M; Guise T; Colangeli S; Capanna R; Costa L
Nat Rev Dis Primers; 2020 Oct; 6(1):83. PubMed ID: 33060614
[TBL] [Abstract][Full Text] [Related]
13. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
Cornford P; van den Bergh RCN; Briers E; Van den Broeck T; Cumberbatch MG; De Santis M; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Grummet J; Henry AM; der Kwast THV; Lam TB; Lardas M; Liew M; Mason MD; Moris L; Oprea-Lager DE; der Poel HGV; Rouvière O; Schoots IG; Tilki D; Wiegel T; Willemse PM; Mottet N
Eur Urol; 2021 Feb; 79(2):263-282. PubMed ID: 33039206
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Parker C; Castro E; Fizazi K; Heidenreich A; Ost P; Procopio G; Tombal B; Gillessen S;
Ann Oncol; 2020 Sep; 31(9):1119-1134. PubMed ID: 32593798
[No Abstract] [Full Text] [Related]
15. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial.
Palma DA; Olson R; Harrow S; Gaede S; Louie AV; Haasbeek C; Mulroy L; Lock M; Rodrigues GB; Yaremko BP; Schellenberg D; Ahmad B; Senthi S; Swaminath A; Kopek N; Liu M; Moore K; Currie S; Schlijper R; Bauman GS; Laba J; Qu XM; Warner A; Senan S
J Clin Oncol; 2020 Sep; 38(25):2830-2838. PubMed ID: 32484754
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
